Literature DB >> 21216633

TCL-SPION-enhanced MRI for the detection of lymph node metastasis in murine experimental model.

Se-Woong Lim1, Hye-Won Kim, Hong-Yeoung Jun, Seong-Hoon Park, Kwon-Ha Yoon, Hun-Soo Kim, Sangyong Jon, Mi Kyung Yu, Seon-Kwan Juhng.   

Abstract

RATIONALE AND
OBJECTIVES: The aim of this study was to assess the feasibility of thermally cross-linked superparamagnetic iron oxide nanoparticle contrast (TCL-SPION) in magnetic resonance (MR) imaging (MRI) for the detection of lymph node metastasis in experimental model.
MATERIALS AND METHODS: B16F1 human melanoma cells were subcutaneously injected into the thighs of C57BL/6 mice (n = 10). MRI was performed 21 days after tumor injection using a 4.7-T MR scanner. In vivo MRI was performed before and after the intravenous administration of TCL-SPION using T2 fast spin-echo and T2 gradient-echo pulse sequences. Then, ex vivo MR images were obtained for resected inguinal lymph nodes (n = 18) using the same pulse sequences as for in vivo imaging. On the basis of hematoxylin and eosin staining results, the lymph nodes were classified into three groups: group 1, nonmetastatic; group 2, tumor volume <50% of the resected sample; and group 3, tumor volume >50% of the resected sample. Size, signal-to-background ratio, and enhancement pattern were evaluated in each of the three groups on ex vivo images.
RESULTS: The findings observed on ex vivo MR images of 18 inguinal lymph nodes were compared with histopathologic findings. All nodes were classified into three groups: group 1, n = 6; group 2, n = 5; and group 3, n = 7. The sizes of the lymph nodes in group 1 were significantly different from the sizes of those in group 3 (P = .014), but there was no significant difference in lymph node sizes between groups 1 and 2 (P = .792). Signal-to-background ratios of samples in groups 2 and 3 were significantly higher than those of samples in group 1 (P = .045 and P = .007, respectively). Each group of lymph nodes showed characteristic enhancement patterns that were well correlated between the images and pathology, except for one node.
CONCLUSIONS: The features and extent of metastasis in the lymph nodes corresponded to those observed on TCL-SPION-enhanced MR images. TCL-SPION-enhanced MRI is useful for the detection and estimation of lymph node metastasis.
Copyright © 2011 AUR. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21216633     DOI: 10.1016/j.acra.2010.10.017

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  6 in total

1.  Magnetic nanoparticles and their applications in image-guided drug delivery.

Authors:  Mi Kyung Yu; Jinho Park; Sangyong Jon
Journal:  Drug Deliv Transl Res       Date:  2012-02       Impact factor: 4.617

Review 2.  Applications of nanotechnology in dermatology.

Authors:  Lisa A DeLouise
Journal:  J Invest Dermatol       Date:  2012-01-05       Impact factor: 8.551

3.  Differentiation of reactive and tumor metastatic lymph nodes with diffusion-weighted and SPIO-enhanced MRI.

Authors:  Fan Zhang; Lei Zhu; Xinglu Huang; Gang Niu; Xiaoyuan Chen
Journal:  Mol Imaging Biol       Date:  2013-02       Impact factor: 3.488

4.  Anti-CEA loaded maghemite nanoparticles as a theragnostic device for colorectal cancer.

Authors:  Mariana Campos da Paz; Maria de Fátima M Almeida Santos; Camila M B Santos; Sebastião W da Silva; Lincoln Bernardo de Souza; Emília C D Lima; Renata C Silva; Carolina M Lucci; Paulo César Morais; Ricardo B Azevedo; Zulmira G M Lacava
Journal:  Int J Nanomedicine       Date:  2012-10-04

5.  Comparison of Two Ultrasmall Superparamagnetic Iron Oxides on Cytotoxicity and MR Imaging of Tumors.

Authors:  Mulan Li; Hoe Suk Kim; Lianji Tian; Mi Kyung Yu; Sangyong Jon; Woo Kyung Moon
Journal:  Theranostics       Date:  2012-01-01       Impact factor: 11.556

6.  The value of T2* in differentiating metastatic from benign axillary lymph nodes in patients with breast cancer--a preliminary in vivo study.

Authors:  Chuanming Li; Shan Meng; Xinhua Yang; Jian Wang; Jiani Hu
Journal:  PLoS One       Date:  2014-01-16       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.